NSE to exclude Strides Pharma from F&O segment

Mumbai: The National Stock Exchange of India (NSE) will exclude futures and options (F&O) contracts on Strides Pharma Science from November 1, as it does not meet the enhanced eligibility criteria to remain in derivatives segment.

The existing unexpired contracts of expiry months of August , September and October would continue to be available for trading till their respective expiry and new strikes would also be introduced in the existing contract months.

“Accordingly, no contracts shall be available for trading in the above mentioned security with effect from November 01, 2019,” NSE said in a circular on Strides Pharma.

Shares of Strides Pharma Science on Monday jumped 3.56 per cent or Rs 13.40 to Rs 389.70.